J Narvid1, D McCoy2, S M Dupont2, A Callen2, D Tosun2, J Hellmuth3, V Valcour3. 1. From the Departments of Radiology and Biomedical Imaging (J.N., D.M., S.M.D., A.C., D.T.) jared.narvid@ucsf.edu. 2. From the Departments of Radiology and Biomedical Imaging (J.N., D.M., S.M.D., A.C., D.T.). 3. Neurology (J.H., V.V.), University of California at San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California.
Abstract
BACKGROUND AND PURPOSE: The aging HIV-infected (HIV+) population has increased vascular comorbidities, including stroke, and increased cognitive deficits compared with the general population. Arterial spin-labeling is a technique to measure cerebral blood flow and is more sensitive than regional volume loss in assessing neurodegenerative diseases and cognitive aging. Previous studies have found global cerebral perfusion abnormalities in the HIV+ participants. In this study, we evaluated the specific regional pattern of CBF abnormalities in older HIV+ participants using quantitative whole-brain arterial spin-labeling. MATERIALS AND METHODS: CBF data from the UCSF HIV Over 60 Cohort and the Alzheimer Disease Neuroimaging Initiative were retrospectively evaluated to identify 19 HIV+ older adults, all with plasma viral suppression (including 5 with HIV-associated neurocognitive disorder); 13 healthy, age-matched controls; and 19 participants with early mild cognitive impairment. CBF values were averaged by ROI and compared among the 3 groups using generalized linear models. RESULTS: When we accounted for age, education, sex, and vascular risk factors, the HIV+ participants demonstrated alterations in regional cerebral perfusion, including hypoperfusion of bilateral temporal, parietal, and occipital brain regions compared with both clinically healthy participants and those with mild cognitive impairment. Arterial spin-labeling showed reasonable test characteristics in distinguishing those with HIV-associated neurocognitive disorder from healthy controls and participants with mild cognitive impairment. CONCLUSIONS: This study found specific CBF patterns associated with HIV status despite viral suppression-data that should animate further investigations into the pathobiologic basis of vascular and cognitive abnormalities in HIV-associated neurocognitive disorders.
BACKGROUND AND PURPOSE: The aging HIV-infected (HIV+) population has increased vascular comorbidities, including stroke, and increased cognitive deficits compared with the general population. Arterial spin-labeling is a technique to measure cerebral blood flow and is more sensitive than regional volume loss in assessing neurodegenerative diseases and cognitive aging. Previous studies have found global cerebral perfusion abnormalities in the HIV+ participants. In this study, we evaluated the specific regional pattern of CBF abnormalities in older HIV+ participants using quantitative whole-brain arterial spin-labeling. MATERIALS AND METHODS:CBF data from the UCSF HIV Over 60 Cohort and the Alzheimer Disease Neuroimaging Initiative were retrospectively evaluated to identify 19 HIV+ older adults, all with plasma viral suppression (including 5 with HIV-associated neurocognitive disorder); 13 healthy, age-matched controls; and 19 participants with early mild cognitive impairment. CBF values were averaged by ROI and compared among the 3 groups using generalized linear models. RESULTS: When we accounted for age, education, sex, and vascular risk factors, the HIV+ participants demonstrated alterations in regional cerebral perfusion, including hypoperfusion of bilateral temporal, parietal, and occipital brain regions compared with both clinically healthy participants and those with mild cognitive impairment. Arterial spin-labeling showed reasonable test characteristics in distinguishing those with HIV-associated neurocognitive disorder from healthy controls and participants with mild cognitive impairment. CONCLUSIONS: This study found specific CBF patterns associated with HIV status despite viral suppression-data that should animate further investigations into the pathobiologic basis of vascular and cognitive abnormalities in HIV-associated neurocognitive disorders.
Authors: Felicia C Chow; W John Boscardin; Claire Mills; Nerissa Ko; Courtney Carroll; Richard W Price; Steven Deeks; Farzaneh A Sorond; Priscilla Y Hsue Journal: AIDS Date: 2016-01-02 Impact factor: 4.177
Authors: R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant Journal: Neurology Date: 2010-12-07 Impact factor: 9.910
Authors: Ryan Sanford; Ana Lucia Fernandez Cruz; Susan C Scott; Nancy E Mayo; Lesley K Fellows; Beau M Ances; D Louis Collins Journal: J Acquir Immune Defic Syndr Date: 2017-04-15 Impact factor: 3.731
Authors: Julia E Hood; Matthew R Golden; James P Hughes; Steven M Goodreau; Azfar-E-Alam Siddiqi; Susan E Buskin; Stephen E Hawes Journal: AIDS Care Date: 2017-04-10
Authors: Felicia C Chow; Susan Regan; Markella V Zanni; Sara E Looby; Cheryl D Bushnell; James B Meigs; Steven K Grinspoon; Steve K Feske; Virginia A Triant Journal: AIDS Date: 2018-01-02 Impact factor: 4.177
Authors: Benjamin B Gelman; Tiansheng Chen; Joshua G Lisinicchia; Vicki M Soukup; J Russ Carmical; Jonathan M Starkey; Eliezer Masliah; Deborah L Commins; Dianne Brandt; Igor Grant; Elyse J Singer; Andrew J Levine; Jeremy Miller; Jessica M Winkler; Howard S Fox; Bruce A Luxon; Susan Morgello Journal: PLoS One Date: 2012-09-26 Impact factor: 3.240
Authors: Andrew L Callen; Sara M Dupont; Jeffrey Pyne; Jason Talbott; Phyllis Tien; Evan Calabrese; David Saloner; Felicia C Chow; Jared Narvid Journal: J Neurovirol Date: 2020-06-04 Impact factor: 2.643
Authors: Yoelvis Garcia-Mesa; Rolando Garza; Maria E Diaz Ortiz; Analise L Gruenewald; Brandon L Bastien; Rebecca Lobrovich; David J Irwin; Michael R Betts; Guido Silvestri; Dennis L Kolson Journal: J Virol Date: 2020-09-15 Impact factor: 5.103